Monday, March 17, 2008

“Animation.” Encyclopedia Britannica. 2008. Encyclopedia Britannica Online.
“2D Animation.” (2008): 8 pp. On-line. Internet. 5 Mar. 2008. Available: www.privatelessons.net.
James, Patrick. “History of Animation: Before Disney.” (1997): 2pp. On-line. Internet. 6 Mar. 2008. Available: www.viz.tamu.edu.
Hammontree, Marie. Walt Disney. New York: Aladdin Paperbacks, 1997.
McNamara, Mary. “Giving an earful to animation viewers.” Los Angeles Times. 27 Feb. 2005.
Schnickel, Richard. “Wlat Disney.” TIME Magazine. 7 Dec. 1998. 1-3.
Owen, G. Scott. “Introduction to Computer Animation.” (8 Feb. 2000) 1 pp. On-line. Internet. 10 Mar. 2008. Available: www.siggraph.org.
“Walt Disney Quotes.” (2008). 1 pp. On-line. 12 Mar. 2008. Available: www.brainyquote.com.

Tuesday, March 11, 2008

notes

Most treatable neurological condition
20,000-50,000 new cases/yr
No cure yet
The disease appears typically in the sixth and seventh decades, although occasionally it can begin as early as the third decade
estimated to be about 187 per 100,000 persons
As the disease progresses, the face of the patient becomes expressionless, the rate of swallowing is reduced, leading to drooling, and depression and dementia increase
motor disorder
Related to brain
characterized by the onset of a “pill rolling” rhythmic tremor, muscle rigidity, difficulty and slowness in movement, and stooped posture
Neurons
10 billion in normal brain
Each neuron transmit signals to ~10,000 other neurons in circuit
A marked decrease in the level of dopamine, a major neurotransmitter, has been noted in the brains of patients with Parkinson's disease
Symptoms
Can affect hands, arms, legs, jaw, and face
Tremor usually begins in hands, sometimes in foot or jaw
~75% never develop significant tremor
Stiffness or rigidness of muscles in limbs due to failure to relax muscles—causes aching, weakness, and jerky movements
Bradykinesia: Slowed ability to start and continue movements, and impaired ability to adjust the body's position (medterms.com)
Impaired balance and coordination
Presymptomatic phase
Slight weakness in extremity
Mood changes
Changes in posture
Dizziness
Handwriting problems
Memory problems
Stages
Stage 1
Signs and symptoms appear only on one side of the body
Symptoms are mild
Symptoms inconvenient, but not disabling
Tremor usually present in one limb
Friends and family have noticed difference in posture, movement, and facial expression
Stage 2
Symptoms appear on both sides of the body
Symptoms cause minimal disability
Posture and gait (manner of walking) are affected
Stage 3
Body movements slow significantly
Have moderately severe problems with normal functioning
Stage 4
Severe symptoms
Able to walk at limited extent
Rigidity and slowness of movement
No longer able to live alone

Commonality
More PD patients than MS (multiple sclerosis), MD (muscular dystrophy), and ALS (Lou Gehrig’s Disease) combined
Average age for PD onset is 61
~1/3 of all cases occur in people under 50
Causes
Oxidative damage

encyclopedia britannica

Parkinson's disease is a motor disorder characterized by the onset of a “pill rolling” rhythmic tremor, muscle rigidity, difficulty and slowness in movement, and stooped posture. As the disease progresses, the face of the patient becomes expressionless, the rate of swallowing is reduced, leading to drooling, and depression and dementia increase. The prevalence of Parkinson's disease is estimated to be about 187 per 100,000 persons in the general population, with about 20 new cases per 100,000 appearing each year. Men are slightly more affected than women, and there are no apparent racial differences. The disease appears typically in the sixth and seventh decades, although occasionally it can begin as early as the third decade. While the majority of cases of Parkinson's disease are of unknown cause, the disease was linked to a complication of encephalitis that developed following the worldwide outbreak of influenza during World War I and, more recently, to an episode of use by intravenous drug abusers of a synthetic drug similar to heroin. A marked decrease in the level of dopamine, a major neurotransmitter, has been noted in the brains of patients with Parkinson's disease, and this change has been attributed to the loss of so-called dopaminergic neurons that normally synthesize and use dopamine to communicate with other neurons in parts of the brain that regulate motor function. This information has opened a new approach to the treatment of the disease—namely, administration of the metabolic precursor to dopamine (L-dopa) that can be converted by the body to dopamine. Although initially beneficial in causing a significant remission of symptoms, L-dopa frequently is effective for only 5 to 10 years, and serious side effects accompany treatment. Cotreatment with an inhibitor of the enzyme that breaks down L-dopa and thus allows the substance to remain in the brain longer has yielded an effective therapy, which allows many patients to live reasonably normal lives. Treatment of the disease with fetal tissue transplants, while raising ethical and legal issues, also has shown promise in alleviating symptoms. Nevertheless, although treatment may slow the progress of the disease, it does not alter its course. This suggests that factors other than variation in neurotransmitter levels are responsible for the disease.

bib

Ahlskog, J. Eric. The Parkinson's Disease Treatment Book. Oxford: Oxford University Press, 2005.

"Human Disease." Encyclopedia Britannica. Online. 2008 ed.

Cram, David L. Understanding Parkinson's Disease. Omaha: Addicus Books, 1999.

"Definition of Bradykinesia." Medicine.net. Online. 2008 ed.